Scientist jumps from Jones Day to expand rival’s biotech offering

US firm’s new partner “brings a rare combination of scientific depth, global perspective, and strategic legal insight” to her new employer’s life sciences practice.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Senior four-partner team leaves A&O Shearman

16 January 2026 The team, known for pharmaceutical and biotechnology patent litigation—including Hatch-Waxman and BPCIA disputes—as well as trade secret and licensing matters, joins a rival US firm.

Careers

Senior USPTO solicitor steps into private practice

14 January 2026 A high-profile departure from the USPTO sees a senior appellate expert move into private practice as demand increases in the firm's life sciences IP practice.

Careers

Goodwin targets transatlantic patent work with London hire

14 January 2026 The US firm has recruited a European patent attorney with three decades of experience to build its patent prosecution offering across the continent.

More features

Chinese biotech strikes billion dollar deal in nextgen cancer race

$5.4bn medtech leader fails to bury a rival's patent

Senior four-partner team leaves A&O Shearman

Final call: Who are the world’s best in-house counsel?

ITC to probe Oura Ring after Samsung retaliates, seeking import ban

Speciality pharma firm stumbles on bid to enforce Belbuca ruling

Italian medtech startup beats larger US rival in UPC dispute

Senior USPTO solicitor steps into private practice

Scientist jumps from Jones Day to expand rival’s biotech offering

More on this story

Editor's picks

Editor's picks

More features